Nunes, S.S.; de Oliveira Silva, J.; Fernandes, R.S.; Miranda, S.E.M.; Leite, E.A.; de Farias, M.A.; Portugal, R.V.; Cassali, G.D.; Townsend, D.M.; Oliveira, M.C.;
et al. PEGylated versus Non-PEGylated pH-Sensitive Liposomes: New Insights from a Comparative Antitumor Activity Study. Pharmaceutics 2022, 14, 272.
https://doi.org/10.3390/pharmaceutics14020272
AMA Style
Nunes SS, de Oliveira Silva J, Fernandes RS, Miranda SEM, Leite EA, de Farias MA, Portugal RV, Cassali GD, Townsend DM, Oliveira MC,
et al. PEGylated versus Non-PEGylated pH-Sensitive Liposomes: New Insights from a Comparative Antitumor Activity Study. Pharmaceutics. 2022; 14(2):272.
https://doi.org/10.3390/pharmaceutics14020272
Chicago/Turabian Style
Nunes, Shirleide Santos, Juliana de Oliveira Silva, Renata Salgado Fernandes, Sued Eustaquio Mendes Miranda, Elaine Amaral Leite, Marcelo Alexandre de Farias, Rodrigo Villares Portugal, Geovanni Dantas Cassali, Danyelle M. Townsend, Mônica Cristina Oliveira,
and et al. 2022. "PEGylated versus Non-PEGylated pH-Sensitive Liposomes: New Insights from a Comparative Antitumor Activity Study" Pharmaceutics 14, no. 2: 272.
https://doi.org/10.3390/pharmaceutics14020272
APA Style
Nunes, S. S., de Oliveira Silva, J., Fernandes, R. S., Miranda, S. E. M., Leite, E. A., de Farias, M. A., Portugal, R. V., Cassali, G. D., Townsend, D. M., Oliveira, M. C., & de Barros, A. L. B.
(2022). PEGylated versus Non-PEGylated pH-Sensitive Liposomes: New Insights from a Comparative Antitumor Activity Study. Pharmaceutics, 14(2), 272.
https://doi.org/10.3390/pharmaceutics14020272
